TAOX · TAO Synergies Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-18 | Ephron Robert |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following May 18, 2026. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-05-18 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following May 18, 2026. |
Stock Option (Right to Buy)
|
30,000 |
| 2026-05-18 | Silverman Joshua |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following May 18, 2026. |
Stock Option (Right to Buy)
|
200,000 |
| 2026-05-18 | Singer William S. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following May 18, 2026. |
Stock Option (Right to Buy)
|
35,000 |
| 2026-05-18 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following May 18, 2026. |
Stock Option (Right to Buy)
|
55,000 |
| 2026-04-07 | Ephron Robert |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 7, 2026. |
Stock Option (Right to Buy)
|
800 |
| 2026-04-07 | Singer William S. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 7, 2026. |
Stock Option (Right to Buy)
|
800 |
| 2026-04-07 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 7, 2026. |
Stock Option (Right to Buy)
|
800 |
| 2025-10-17 | Bernstein Bruce |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
10,000 |
| 2025-10-17 | Silverman Joshua |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
40,000 |
| 2025-10-17 | Ephron Robert |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
3,000 |
| 2025-10-17 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 25,000 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the "Issuer") 2020 Equity Incentive Plan which vested immediately and (ii) 15,897 shares of common stock. |
Common Stock, par value $0.0001 per share
|
25,000 |
| 2025-10-17 | Silverman Joshua |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 100,000 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the "Issuer") 2020 Equity Incentive Plan which vested immediately and (ii) 26,681 shares of common stock. |
Common Stock, par value $0.0001 per share
|
100,000 |
| 2025-10-17 | Ephron Robert |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 7,500 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the "Issuer") 2020 Equity Incentive Plan which vested immediately. |
Common Stock, par value $0.0001 per share
|
7,500 |
| 2025-10-17 | Singer William S. |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
6,000 |
| 2025-10-17 | WEINSTEIN ROBERT |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
4,000 |
| 2025-10-17 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 10,000 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the "Issuer") 2020 Equity Incentive Plan which vested immediately and (ii) 10,574 shares of common stock. |
Common Stock, par value $0.0001 per share
|
10,000 |
| 2025-10-17 | Singer William S. |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 15,000 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the "Issuer") 2020 Equity Incentive Plan which vested immediately and (ii) 10,566 shares of common stock. |
Common Stock, par value $0.0001 per share
|
15,000 |
| 2025-08-06 | TUCHMAN ALAN J |
Director, Chief Medical Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. |
Employee Stock Option (right to buy)
|
2,000 |
| 2025-08-06 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option grant was approved by a committee of the Issuer's board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. |
Employee Stock Option (right to buy)
|
7,000 |
| 2025-08-06 | Silverman Joshua |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option grant was approved by a committee of the Issuer's board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. |
Employee Stock Option (right to buy)
|
36,000 |
| 2025-08-06 | Singer William S. |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option grant was approved by a committee of the Issuer's board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. |
Employee Stock Option (right to buy)
|
7,000 |
| 2025-08-06 | SCHECHTER JONATHAN |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Issuer's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Issuer received shareholder approval of the amendment to the Plan on August 6, 2025. |
Employee Stock Option (right to buy)
|
10,000 |
| 2025-08-06 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option grant was approved by a committee of the Issuer's board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. |
Employee Stock Option (right to buy)
|
12,000 |
| 2025-06-30 | WEINSTEIN ROBERT |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
6,164 |
| 2025-06-30 | Singer William S. |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 15,410 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,320 shares of common stock. |
Common Stock, par value $0.0001 per share
|
15,410 |
| 2025-06-30 | SCHECHTER JONATHAN |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
8,630 |
| 2025-06-30 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 15,410 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,328 shares of common stock. |
Common Stock, par value $0.0001 per share
|
15,410 |
| 2025-06-30 | Singer William S. |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
6,164 |
| 2025-06-30 | Silverman Joshua |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
16,768 |
| 2025-06-30 | Silverman Joshua |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 41,919 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,530 shares of common stock. |
Common Stock, par value $0.0001 per share
|
41,919 |
| 2025-06-30 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 24,657 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,103 shares of common stock. |
Common Stock, par value $0.0001 per share
|
24,657 |
| 2025-06-30 | Bernstein Bruce |
Director |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
9,863 |
| 2025-06-30 | TUCHMAN ALAN J |
Director, Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
Common Stock, par value $0.0001 per share
|
1,726 |
| 2025-06-30 | SCHECHTER JONATHAN |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 21,575 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,090 shares of common stock. |
Common Stock, par value $0.0001 per share
|
21,575 |
| 2025-06-30 | TUCHMAN ALAN J |
Director, Chief Medical Officer |
Award↑
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Includes (i) 4,315 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,320 shares of common stock. |
Common Stock, par value $0.0001 per share
|
4,315 |
| 2025-04-03 | Singer William S. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 3, 2025. |
Stock Option (Right to Buy)
|
800 |
| 2025-04-03 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 3, 2025. |
Stock Option (Right to Buy)
|
800 |
| 2025-04-03 | SCHECHTER JONATHAN |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 3, 2025. |
Stock Option (Right to Buy)
|
800 |
| 2024-04-08 | SCHECHTER JONATHAN |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 8, 2024. |
Stock Option (Right to Buy)
|
800 |
| 2024-04-08 | Singer William S. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 8, 2024. |
Stock Option (Right to Buy)
|
800 |
| 2024-04-08 | Silverman Joshua |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 8, 2024. |
Stock Option (Right to Buy)
|
800 |
| 2024-04-08 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 8, 2024. |
Stock Option (Right to Buy)
|
800 |
| 2023-03-29 | Silverman Joshua |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following March 29, 2023. |
Stock Option (Right to Buy)
|
20,000 |
| 2023-03-29 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following March 29, 2023. |
Stock Option (Right to Buy)
|
20,000 |
| 2023-03-29 | SCHECHTER JONATHAN |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following March 29, 2023. |
Stock Option (Right to Buy)
|
20,000 |
| 2023-03-29 | Singer William S. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following March 29, 2023. |
Stock Option (Right to Buy)
|
20,000 |
| 2022-12-16 | Silverman Joshua |
Director |
Sell↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
Common Stock, par value $0.0001 per share
|
19,012 |
| 2022-12-16 | Bernstein Bruce |
Director |
Sell↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
Common Stock, par value $0.0001 per share
|
22,500 |
| 2022-12-16 | WEINSTEIN ROBERT |
Director |
Sell↓
Filing footnotes — Common Stock, par value $0.0001 per share (Direct)
Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
Common Stock, par value $0.0001 per share
|
27,000 |